市場調査レポート：世界のグループACYW135髄膜炎菌多糖ワクチン市場（～2028年）：クラスIワクチン、クラスIIワクチン

• 英文タイトル：Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Insights, Forecast to 2028

Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Insights, Forecast to 2028「世界のグループACYW135髄膜炎菌多糖ワクチン市場（～2028年）：クラスIワクチン、クラスIIワクチン」（市場規模、市場予測）調査レポートです。

• レポートコード：MRC2Q12-19083
• 出版社/出版日：QYResearch / 2022年12月
• レポート形態：英文、PDF、111ページ
• 納品方法：Eメール（納期：3営業日）
• 産業分類：医薬品＆医療

• 販売価格（消費税別）

Single User	￥725,200 (USD4,900)	▷ お問い合わせ
Enterprise License	￥1,450,400 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、グループACYW135髄膜炎菌多糖ワクチンのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。
グループACYW135髄膜炎菌多糖ワクチンのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
グループACYW135髄膜炎菌多糖ワクチンの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。
グループACYW135髄膜炎菌多糖ワクチンのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。

生産面において、本レポートは2017年から2022年までのグループACYW135髄膜炎菌多糖ワクチンの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のグループACYW135髄膜炎菌多糖ワクチンの売上および2028年までの予測に焦点を当てています。

グループACYW135髄膜炎菌多糖ワクチンのグローバル主要企業には、Sanofi-Pasteur、Walvax Biotechnology、Chengdu Kanghua Biological Products Co., Ltd、Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd、Zhejiang Tianyuan Biopharmaceutical Co., Ltd、Beijing Institute of Biological Products Co., Ltd、CanSino Biologics AG、Yuxi Watson Biotechnology Co., Ltd、Hualan Biovaccine Co., Ltd、Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

グループACYW135髄膜炎菌多糖ワクチン市場は、タイプとアプリケーションによって区分されます。世界のグループACYW135髄膜炎菌多糖ワクチン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。

【タイプ別セグメント】
クラスIワクチン、クラスIIワクチン

【アプリケーション別セグメント】
病院、診療所

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- グループACYW135髄膜炎菌多糖ワクチン製品概要
- タイプ別市場（クラスIワクチン、クラスIIワクチン）
- アプリケーション別市場（病院、診療所）
- 調査の目的
・エグゼクティブサマリー
- 世界のグループACYW135髄膜炎菌多糖ワクチン販売量予測2017-2028
- 世界のグループACYW135髄膜炎菌多糖ワクチン売上予測2017-2028
- グループACYW135髄膜炎菌多糖ワクチンの地域別販売量
- グループACYW135髄膜炎菌多糖ワクチンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別グループACYW135髄膜炎菌多糖ワクチン販売量
- 主要メーカー別グループACYW135髄膜炎菌多糖ワクチン売上
- 主要メーカー別グループACYW135髄膜炎菌多糖ワクチン価格
- 競争状況の分析
- 企業M&A動向
・タイプ別市場規模（クラスIワクチン、クラスIIワクチン）
- グループACYW135髄膜炎菌多糖ワクチンのタイプ別販売量
- グループACYW135髄膜炎菌多糖ワクチンのタイプ別売上
- グループACYW135髄膜炎菌多糖ワクチンのタイプ別価格
・アプリケーション別市場規模（病院、診療所）
- グループACYW135髄膜炎菌多糖ワクチンのアプリケーション別販売量
- グループACYW135髄膜炎菌多糖ワクチンのアプリケーション別売上
- グループACYW135髄膜炎菌多糖ワクチンのアプリケーション別価格
・北米市場
- 北米のグループACYW135髄膜炎菌多糖ワクチン市場規模（タイプ別、アプリケーション別）
- 主要国別のグループACYW135髄膜炎菌多糖ワクチン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのグループACYW135髄膜炎菌多糖ワクチン市場規模（タイプ別、アプリケーション別）
- 主要国別のグループACYW135髄膜炎菌多糖ワクチン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のグループACYW135髄膜炎菌多糖ワクチン市場規模（タイプ別、アプリケーション別）
- 主要国別のグループACYW135髄膜炎菌多糖ワクチン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のグループACYW135髄膜炎菌多糖ワクチン市場規模（タイプ別、アプリケーション別）
- 主要国別のグループACYW135髄膜炎菌多糖ワクチン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのグループACYW135髄膜炎菌多糖ワクチン市場規模（タイプ別、アプリケーション別）
- 主要国別のグループACYW135髄膜炎菌多糖ワクチン市場規模（トルコ、サウジアラビア）
・企業情報
Sanofi-Pasteur、Walvax Biotechnology、Chengdu Kanghua Biological Products Co., Ltd、Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd、Zhejiang Tianyuan Biopharmaceutical Co., Ltd、Beijing Institute of Biological Products Co., Ltd、CanSino Biologics AG、Yuxi Watson Biotechnology Co., Ltd、Hualan Biovaccine Co., Ltd、Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
・産業チェーン及び販売チャネル分析
- グループACYW135髄膜炎菌多糖ワクチンの産業チェーン分析
- グループACYW135髄膜炎菌多糖ワクチンの原材料
- グループACYW135髄膜炎菌多糖ワクチンの生産プロセス
- グループACYW135髄膜炎菌多糖ワクチンの販売及びマーケティング
- グループACYW135髄膜炎菌多糖ワクチンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- グループACYW135髄膜炎菌多糖ワクチンの産業動向
- グループACYW135髄膜炎菌多糖ワクチンのマーケットドライバー
- グループACYW135髄膜炎菌多糖ワクチンの課題
- グループACYW135髄膜炎菌多糖ワクチンの阻害要因
・主な調査結果

Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Group ACYW135 Meningococcal Polysaccharide Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine include Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Group ACYW135 Meningococcal Polysaccharide Vaccine market. Further, it explains the major drivers and regional dynamics of the global Group ACYW135 Meningococcal Polysaccharide Vaccine market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sanofi-Pasteur
Walvax Biotechnology
Chengdu Kanghua Biological Products Co., Ltd
Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
Zhejiang Tianyuan Biopharmaceutical Co., Ltd
Beijing Institute of Biological Products Co., Ltd
CanSino Biologics AG
Yuxi Watson Biotechnology Co., Ltd
Hualan Biovaccine Co., Ltd
Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Type
Class I Vaccines
Class II Vaccines
Group ACYW135 Meningococcal Polysaccharide Vaccine Segment by Application
Hospital
Clinic
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Group ACYW135 Meningococcal Polysaccharide Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Group ACYW135 Meningococcal Polysaccharide Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Group ACYW135 Meningococcal Polysaccharide Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Group ACYW135 Meningococcal Polysaccharide Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Group ACYW135 Meningococcal Polysaccharide Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Group ACYW135 Meningococcal Polysaccharide Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Group ACYW135 Meningococcal Polysaccharide Vaccine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sanofi-Pasteur, Walvax Biotechnology, Chengdu Kanghua Biological Products Co., Ltd, Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd, Zhejiang Tianyuan Biopharmaceutical Co., Ltd, Beijing Institute of Biological Products Co., Ltd, CanSino Biologics AG, Yuxi Watson Biotechnology Co., Ltd and Hualan Biovaccine Co., Ltd, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Group ACYW135 Meningococcal Polysaccharide Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Group ACYW135 Meningococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Group ACYW135 Meningococcal Polysaccharide Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Class I Vaccines
1.2.3 Class II Vaccines
1.3 Market by Application
1.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region
2.4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Group ACYW135 Meningococcal Polysaccharide Vaccine by Region (2023-2028)
2.5 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region
2.5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2022)
2.5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Manufacturers
3.1.1 Global Top Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Group ACYW135 Meningococcal Polysaccharide Vaccine in 2021
3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturers
3.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue in 2021
3.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type
4.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type
4.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type
4.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Type (2017-2022)
4.3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application
5.1.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application
5.2.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application
5.3.1 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price by Application (2017-2022)
5.3.2 Global Group ACYW135 Meningococcal Polysaccharide Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
6.1.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
6.1.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
6.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
6.2.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
6.2.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
6.3 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
6.3.1 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2028)
6.3.2 North America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
7.1.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
7.1.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
7.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
7.2.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
7.2.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
7.3 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
7.3.1 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2028)
7.3.2 Europe Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
8.1.1 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
8.2.1 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Region
8.3.1 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
9.1.1 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
9.2 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
9.2.1 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
9.3 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
9.3.1 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Type
10.1.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Application
10.2.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Market Size by Country
10.3.1 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Group ACYW135 Meningococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Sanofi-Pasteur
11.1.1 Sanofi-Pasteur Corporation Information
11.1.2 Sanofi-Pasteur Overview
11.1.3 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Sanofi-Pasteur Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Sanofi-Pasteur Recent Developments
11.2 Walvax Biotechnology
11.2.1 Walvax Biotechnology Corporation Information
11.2.2 Walvax Biotechnology Overview
11.2.3 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Walvax Biotechnology Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Walvax Biotechnology Recent Developments
11.3 Chengdu Kanghua Biological Products Co., Ltd
11.3.1 Chengdu Kanghua Biological Products Co., Ltd Corporation Information
11.3.2 Chengdu Kanghua Biological Products Co., Ltd Overview
11.3.3 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chengdu Kanghua Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengdu Kanghua Biological Products Co., Ltd Recent Developments
11.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd
11.4.1 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Corporation Information
11.4.2 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Overview
11.4.3 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Beijing Zhifei Luzhu Biopharmaceutical Co., Ltd Recent Developments
11.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd
11.5.1 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Corporation Information
11.5.2 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Overview
11.5.3 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhejiang Tianyuan Biopharmaceutical Co., Ltd Recent Developments
11.6 Beijing Institute of Biological Products Co., Ltd
11.6.1 Beijing Institute of Biological Products Co., Ltd Corporation Information
11.6.2 Beijing Institute of Biological Products Co., Ltd Overview
11.6.3 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Beijing Institute of Biological Products Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Beijing Institute of Biological Products Co., Ltd Recent Developments
11.7 CanSino Biologics AG
11.7.1 CanSino Biologics AG Corporation Information
11.7.2 CanSino Biologics AG Overview
11.7.3 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 CanSino Biologics AG Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CanSino Biologics AG Recent Developments
11.8 Yuxi Watson Biotechnology Co., Ltd
11.8.1 Yuxi Watson Biotechnology Co., Ltd Corporation Information
11.8.2 Yuxi Watson Biotechnology Co., Ltd Overview
11.8.3 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Yuxi Watson Biotechnology Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Yuxi Watson Biotechnology Co., Ltd Recent Developments
11.9 Hualan Biovaccine Co., Ltd
11.9.1 Hualan Biovaccine Co., Ltd Corporation Information
11.9.2 Hualan Biovaccine Co., Ltd Overview
11.9.3 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Hualan Biovaccine Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hualan Biovaccine Co., Ltd Recent Developments
11.10 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd
11.10.1 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Corporation Information
11.10.2 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Overview
11.10.3 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Group ACYW135 Meningococcal Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Aimei Weixin Biopharmaceutical (Zhejiang) Co., Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Chain Analysis
12.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Production Mode & Process
12.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales and Marketing
12.4.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Sales Channels
12.4.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Distributors
12.5 Group ACYW135 Meningococcal Polysaccharide Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Group ACYW135 Meningococcal Polysaccharide Vaccine Industry Trends
13.2 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Drivers
13.3 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Challenges
13.4 Group ACYW135 Meningococcal Polysaccharide Vaccine Market Restraints
14 Key Findings in The Global Group ACYW135 Meningococcal Polysaccharide Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer